With Washington state introducing the possibility of introducing a ballot initiative to require the labeling of foods with genetically modified ingredients, major food companies and advocacy groups have been began pushing for a uniform system of food labeling.

Biotechnology firms have been increasing their lobbying efforts to limit generic competition of their top-selling drugs, citing research costs, patient safety, and loss of revenue. Several states have already begun considering these proposals and acting upon them.